Header Logo

Connection

ALI DENKTAS to Female

Back to Details
This is a "connection" page, showing publications ALI DENKTAS has written about Female.
ALI DENKTAS
Connection Strength
0.204
Female
  1. Prehospital fibrinolysis followed by urgent percutaneous coronary intervention after ST-elevation myocardial infarction. Future Cardiol. 2018 05 01; 14(3):193-195.
    View in: PubMed
    Score: 0.024
  2. Suspected coronary fat embolism after liposuction. Catheter Cardiovasc Interv. 2018 12 01; 92(7):E449-E452.
    View in: PubMed
    Score: 0.023
  3. TAVI in patients with left ventricular dysfunction: worse outcomes or greatest chance for improvement? J Invasive Cardiol. 2014 Mar; 26(3):139.
    View in: PubMed
    Score: 0.018
  4. Cardiac arrest and ventricular tachycardia from coronary embolism: an unusual presentation of infective endocarditis. Anadolu Kardiyol Derg. 2014 Mar; 14(2):204-5.
    View in: PubMed
    Score: 0.018
  5. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry. JACC Cardiovasc Interv. 2008 Oct; 1(5):504-10.
    View in: PubMed
    Score: 0.012
  6. Mortality differences among patients with in-hospital ST-elevation myocardial infarction. Clin Cardiol. 2020 Dec; 43(12):1555-1561.
    View in: PubMed
    Score: 0.007
  7. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction. Cardiovasc Drugs Ther. 2021 06; 35(3):575-585.
    View in: PubMed
    Score: 0.007
  8. Outcomes of Reoperative Coronary Artery Bypass Graft Surgery in the United States. J Am Heart Assoc. 2020 08 04; 9(15):e016282.
    View in: PubMed
    Score: 0.007
  9. Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair and Surgical Mitral Valve Intervention. Cardiovasc Revasc Med. 2020 12; 21(12):1560-1566.
    View in: PubMed
    Score: 0.007
  10. Temporal trends, outcomes, and predictors of mortality after pericardiocentesis in the United States. Catheter Cardiovasc Interv. 2020 02 15; 95(3):375-386.
    View in: PubMed
    Score: 0.007
  11. Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
    View in: PubMed
    Score: 0.006
  12. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.006
  13. Safety and efficacy of coil embolization of the septal perforator for septal ablation in patients with hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv. 2016 Nov 15; 88(6):971-977.
    View in: PubMed
    Score: 0.005
  14. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
    View in: PubMed
    Score: 0.005
  15. Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol. 2016 09 15; 118(6):854-859.
    View in: PubMed
    Score: 0.005
  16. Comparison of the use of hemodynamic support in patients =80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study). Am J Cardiol. 2014 Sep 01; 114(5):657-64.
    View in: PubMed
    Score: 0.005
  17. Comparison of outcomes for patients =75 years of age treated with pre-hospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2014 Jan 01; 113(1):60-3.
    View in: PubMed
    Score: 0.004
  18. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction. Am J Cardiol. 2013 Jun 01; 111(11):1576-9.
    View in: PubMed
    Score: 0.004
  19. The pre-hospital fibrinolysis experience in Europe and North America and implications for wider dissemination. JACC Cardiovasc Interv. 2011 Aug; 4(8):877-83.
    View in: PubMed
    Score: 0.004
  20. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 08; 54(24):2277-86.
    View in: PubMed
    Score: 0.003
  21. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol. 2006 Sep 15; 98(6):729-33.
    View in: PubMed
    Score: 0.003
  22. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol. 2007 May 02; 117(3):365-9.
    View in: PubMed
    Score: 0.003
  23. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina. Eur Heart J. 2006 Jul; 27(14):1678-84.
    View in: PubMed
    Score: 0.003
  24. Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intracoronary brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv. 2004 Oct; 63(2):152-7.
    View in: PubMed
    Score: 0.002
  25. Routine intravascular ultrasound scanning guidance of coronary stenting is not associated with improved clinical outcomes. Am Heart J. 2004 Sep; 148(3):501-6.
    View in: PubMed
    Score: 0.002
  26. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv. 2004 Apr; 61(4):484-91.
    View in: PubMed
    Score: 0.002
  27. Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures. Am Heart J. 2004 Jan; 147(1):140-5.
    View in: PubMed
    Score: 0.002
  28. Right atrial thrombus formation associated with central venous catheters utilization in hemodialysis patients. Intensive Care Med. 2003 Oct; 29(10):1829-32.
    View in: PubMed
    Score: 0.002
  29. Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience. J Invasive Cardiol. 2002 Dec; 14(12):720-4.
    View in: PubMed
    Score: 0.002
  30. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation. 2001 Jul 24; 104(4):412-7.
    View in: PubMed
    Score: 0.002
  31. Independent and incremental value of coronary artery calcium for predicting the extent of angiographic coronary artery disease: comparison with cardiac risk factors and radionuclide perfusion imaging. J Am Coll Cardiol. 1999 Sep; 34(3):777-86.
    View in: PubMed
    Score: 0.002
  32. Contribution of stenting to the results of rescue PTCA. Catheter Cardiovasc Interv. 1999 Aug; 47(4):411-4.
    View in: PubMed
    Score: 0.002
  33. Ventricular septal defect patch causing right ventricular inflow tract obstruction. Circulation. 1999 Jul 13; 100(2):e12-3.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.